Guardian Pharmacy Services, Inc. Stock-Based Compensation
Guardian Pharmacy Services, Inc. (GRDN) reported Stock-Based Compensation of $4.79 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-06
- Guardian Pharmacy Services, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $2.93M, a 34.07% decline year-over-year.
- Guardian Pharmacy Services, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $1.86M, a 53.10% decline year-over-year.
- Guardian Pharmacy Services, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $1.08M, a 68.80% decline year-over-year.
- Guardian Pharmacy Services, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $4.36M, a 96.44% decline year-over-year.
- Guardian Pharmacy Services, Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $13.85M, a 89.47% decline from fiscal 2024.
- Guardian Pharmacy Services, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $131.49M.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $4.79M 10-Q · filed 2026-08-06 | $5.87M derived: sum of 3 quarters · filed 2026-08-06 | $10.23M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $1.86M 10-Q · filed 2026-05-06 | $2.94M derived: sum of 2 quarters · filed 2026-05-06 | $7.30M derived: sum of 3 quarters · filed 2026-05-06 | $11.74M derived: sum of 4 quarters · filed 2026-05-06 |
| 2025-12-31 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $5.44M derived: sum of 2 quarters · filed 2026-03-11 | $9.88M derived: sum of 3 quarters · filed 2026-03-11 | $13.85M 10-K · filed 2026-03-11 |
| 2025-09-30 | $4.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $8.80M derived: sum of 2 quarters · filed 2025-11-10 | $12.77M 10-Q · filed 2025-11-10 | $16.23M derived: sum of 4 quarters · filed 2026-05-06 |
| 2025-06-30 | $4.45M 10-Q · filed 2025-08-11 | $8.41M 10-Q · filed 2026-08-06 | $11.88M derived: sum of 3 quarters · filed 2026-05-06 | $134.23M derived: sum of 4 quarters · filed 2026-05-06 |
| 2025-03-31 | $3.97M 10-Q · filed 2026-05-06 | $7.43M derived: sum of 2 quarters · filed 2026-05-06 | $129.78M derived: sum of 3 quarters · filed 2026-05-06 | $129.51M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $3.46M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $125.82M derived: sum of 2 quarters · filed 2026-03-11 | $125.55M derived: sum of 3 quarters · filed 2026-03-11 | $131.49M 10-K · filed 2026-03-11 |
| 2024-09-30 | $122.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $122.08M derived: sum of 2 quarters · filed 2025-11-10 | $128.03M 10-Q · filed 2025-11-10 | |
| 2024-06-30 | -$272.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $5.67M 10-Q · filed 2025-08-11 | ||
| 2024-03-31 | $5.95M 10-Q · filed 2025-05-12 | |||
| 2023-09-30 | $16.63M 10-Q · filed 2024-11-12 |